MOUNTAIN VALLEY MD INC.
Toronto, A6 · Founded 2018 · CIK 0001769938 · Biotech · Public
Bioactive compounds and formulations for optimizing health across humans, animals, and plants
mvmd.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $18M
- 3 Form D · Feb 2020
- 80 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 10
- 7 granted · 3 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $7,707,782 | |
| Private capital raised | Form D · SEC | $9,135,331 | |
| Private capital raised | Form D · SEC | $1,046,717 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2517 | Metselex, Incorporated | — | — |
| 2518 | Radionetics Oncology | — | $54M |
| 2519 | SIVEC BIOTECHNOLOGIES, INC. | — | $3.3M |
| 2520 | MOUNTAIN VALLEY MD INC. | — | $18M |
| 2521 | Botanix Pharmaceuticals Ltd. | — | $20M |
| 2522 | Quantum Simulation Technologies, Inc. | — | $7.3M |
| 2523 | NeXtGen Biologics, INC | — | $2.9M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Evan CliffordDirector
- Christopher CrupiExecutive Officer
- CHRIS CRUPIExecutive Officer
- DENNIS HANCOCKDirector · Executive Officer
- Michael MonacoDirector · Executive Officer
Patents
- Cannabinoid Monoterpene Based Pharmaceutical Topical Composition For MusculoSkeletal Paingranted
- Water Dissolvable Macrocyclic Lactone Cyclodextrin Complexesgranted
- Cannabinoids Based Pharmaceutical Compositiongranted
- Novel Injectable, Infusable, Instillable Ivermectin Adjuvant For Cancer Therapiesgranted
- Water Dissolvable Macrocyclic Lactone Cyclodextrin Complexesgranted
- Topical Solubilized Ivermectin For Inflammatory Skin Conditionsgranted
- Water Dissolvable Macrocyclic Lactone Cyclodextrin Complexesgranted
- Water Dissolvable Macrocyclic Lactone Cyclodextrin Complexesapplication
- A Porous Aluminum Nanoparticulate Structureapplication
- Novel Injectable, Infusable, Instillable Ivermectin Adjuvant For Cancer Therapiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.